Granzyme b pet as a novel means to assess t-cell activation in response to 177LU-psma-617 priming in metastatic castration-resistant prostate cancer…
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210514
- Recipient
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $685,497
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- San Francisco, CA 94143, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $685,497 Project Grant to the Regents of the University of California, San Francisco through the Military Medical Research and Development program. The grant will fund a research project from July 2022 through July 2025 to develop GRANZYME B PET imaging as a novel method to assess T-cell activation in response to 177LU-PSMA-617 priming in metastatic castration-resistant prostate cancer.
The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving military and public health outcomes. This award will allow researchers at the University of California, San Francisco to investigate using GRANZYME B PET imaging to measure anti-tumor immune responses generated by 177LU-PSMA-617 radionuclide therapy, with the aim of advancing treatment for metastatic castration-resistant prostate cancer.
Quick answers
Who received award W81XWH2210514?
W81XWH2210514 was awarded to The Regents Of The University Of California. San Francisco by Medical Command (Department of the Army) on July 15, 2022.
How much is award W81XWH2210514 worth?
$685,497 has been obligated on W81XWH2210514.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award